Acadia Pharmaceuticals Inc (ACAD) Implied Volatility Current

Tracking ACAD implied volatility helps you identify when options premiums on Acadia Pharmaceuticals Inc are historically cheap or expensive, and where the best trades are hiding. Acadia Pharmaceuticals Inc implied volatility reflects the market's expectation of future price movement: when ACAD IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Acadia Pharmaceuticals Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ACAD, tracking metrics like ACAD IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ACAD signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psychosis, and negative symptoms of schizophrenia; Trofinetide, a novel synthetic analog, under phase 3 development for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic, under phase 2 development for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor, under phase 1 development for treating schizophrenia and cognition in Alzheimer's.

ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ACAD implied volatility sits today versus where it has been. Our scanner ranks Acadia Pharmaceuticals Inc implied volatility against its historical range, surfaces extremes in ACAD IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Acadia Pharmaceuticals Inc IV is rich or cheap — measure it, then act on it.